Yuko Mitobe

ORCID: 0000-0001-8897-8561 · 2 papers in corpus
2025
Advances in therapy ·doi:10.1007/s12325-025-03123-9

IntroductionTreatment interruptions due to adverse drug reactions (ADRs) are common in iron deficiency anemia (IDA). We evaluated medication completion rates and quality of life (QoL) changes in patients with IDA after starting ferric citra…

article 2023
BMC women's health ·doi:10.1186/s12905-023-02652-1

BACKGROUND: The purpose of this study was to establish an estimating equation to predict the 5-level EQ-5D version (EQ-5D-5L) utility score in patients taking iron preparations for heavy menstrual bleeding (HMB) or anemia and to evaluate wh…